Matches in Wikidata for { <http://www.wikidata.org/entity/Q95520329> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q95520329 description "wetenschappelijk artikel" @default.
- Q95520329 description "наукова стаття" @default.
- Q95520329 name "[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)]" @default.
- Q95520329 name "[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)]" @default.
- Q95520329 type Item @default.
- Q95520329 label "[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)]" @default.
- Q95520329 label "[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)]" @default.
- Q95520329 prefLabel "[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)]" @default.
- Q95520329 prefLabel "[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)]" @default.
- Q95520329 P1433 Q95520329-A8357021-0B53-49EB-AB1D-627F06EAEF6A @default.
- Q95520329 P1476 Q95520329-B8DA760E-EDC7-46B5-980D-445797E933E6 @default.
- Q95520329 P2093 Q95520329-40FCB6B4-E039-45D1-BF7C-0C2AC90FF081 @default.
- Q95520329 P2093 Q95520329-52C5B40C-79DB-4225-98A6-88F61C2FEBD4 @default.
- Q95520329 P2093 Q95520329-5339F6CA-E990-46BE-8E55-DD9CD8E08414 @default.
- Q95520329 P2093 Q95520329-59622922-0320-4357-8E20-660518CBA481 @default.
- Q95520329 P2093 Q95520329-B8384EC2-9A43-474C-9123-03758564CBF8 @default.
- Q95520329 P2093 Q95520329-E63729A0-F55A-4BF9-B97C-28A6E19B2DB4 @default.
- Q95520329 P2093 Q95520329-EA13ED01-49C0-4424-8416-25829D745A3E @default.
- Q95520329 P2093 Q95520329-EB128952-185A-41A2-90E4-678C22D2F728 @default.
- Q95520329 P304 Q95520329-40A30407-14DB-4E68-A097-7E5759AE89DE @default.
- Q95520329 P31 Q95520329-8639BAC1-2FAE-4809-BE04-296B9A43A8EE @default.
- Q95520329 P433 Q95520329-B94F72F0-C966-4EF4-9E91-637882D1ACF7 @default.
- Q95520329 P478 Q95520329-C4ACB7A0-1383-49D0-AA4E-5B2DBE74A03B @default.
- Q95520329 P577 Q95520329-F7E8265C-32BA-4380-AB61-B1DD9555E2DE @default.
- Q95520329 P698 Q95520329-BD041180-B98E-4AB7-8F6B-BDC834E248CF @default.
- Q95520329 P921 Q95520329-06B7F199-AA32-45D6-872D-0B24B2AFF353 @default.
- Q95520329 P921 Q95520329-8302D6EA-027A-4451-8AD7-8EC2312FF4B8 @default.
- Q95520329 P921 Q95520329-D2DB24BE-4538-4E52-A2EB-1CC319272A9E @default.
- Q95520329 P698 29650822 @default.
- Q95520329 P1433 Q27709096 @default.
- Q95520329 P1476 "[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)]" @default.
- Q95520329 P2093 "Hiroyasu Oda" @default.
- Q95520329 P2093 "Kanako Saito" @default.
- Q95520329 P2093 "Mikiya Ishihara" @default.
- Q95520329 P2093 "Motohiko Okano" @default.
- Q95520329 P2093 "Naoyuki Katayama" @default.
- Q95520329 P2093 "Satoshi Tamaru" @default.
- Q95520329 P2093 "Toshiro Mizuno" @default.
- Q95520329 P2093 "Yoshiki Yamashita" @default.
- Q95520329 P304 "643-645" @default.
- Q95520329 P31 Q13442814 @default.
- Q95520329 P433 "4" @default.
- Q95520329 P478 "45" @default.
- Q95520329 P577 "2018-04-01T00:00:00Z" @default.
- Q95520329 P698 "29650822" @default.
- Q95520329 P921 Q1076481 @default.
- Q95520329 P921 Q18975959 @default.
- Q95520329 P921 Q418817 @default.